← Back to all earnings calls

Enanta Pharmaceuticals Inc Q2 FY2020 Earnings Call

Enanta Pharmaceuticals Inc (ENTA)

Earnings Call FY2020 Q2 Call date: 2020-05-06 Concluded

Share

Quarter scorecard

Revenue

$27.62M

-30.3% YoY

Diluted EPS

$-0.30

-250% YoY

Net income

-$6.00M

-244.9% YoY

Documents & deck